In vivo enhancement of transdermal absorption of ketotifen by supersaturation generated by amorphous form of the drug

Hansen, 2011, An extended database of keratin binding, J. Pharm. Sci., 100, 1712, 10.1002/jps.22396 Inoue, 2000, The skin permeation mechanism of ketotifen: evaluation of permeation pathways and barrier components in the stratum corneum, Drug Dev. Ind. Pharm., 26, 45, 10.1081/DDC-100100326 Inoue, 2005, Enhancement of skin permeation of ketotifen by supersaturation generated by amorphous form of the drug, J. Cont. Rel., 108, 306, 10.1016/j.jconrel.2005.08.008 Kim, 2002, Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix, Int. J. Pharm., 236, 81, 10.1016/S0939-6411(01)00166-7 Mallick, 2008, Formation of physically stable amorphous phase of ibuprofen by solid state milling with kaolin, Eur. J. Pharm. Biopharm., 68, 346, 10.1016/S0378-5173(02)00017-0 McCarley, 2001, Pharmacokinetic models of dermal absorption, J. Pharm. Sci., 11, 1699, 10.1016/j.ejpb.2007.06.003 Moser, 2001, Passive Skin penetration enhancement and its quantification in vitro, E. J. Pharm. Biopharm., 52, 103, 10.1002/jps.1120 Pellet, 1994, The permeation of solutions of piroxicam across silicon membranes and human skin in vitro, Int. J. Pharm., 111, 1 Pellet, 1997, The permeation of solutions of piroxicam across silicon membranes and human skin in vitro, J. Control. Release, 46, 205, 10.1016/S0168-3659(96)01595-7 Raghavan, 2001, Crystallization of hydrocortisone acetate: influence of polymers, Int. J. Pharm., 212, 213, 10.1016/S0378-5173(00)00610-4 Schwarb, 1999, Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin, Pharm. Res., 16, 909, 10.1023/A:1018890422825